- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 12, 2026 | 1.78M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 3.91M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 2.46M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 526.89K sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 444.9K sh |
| Capex | Q3 2026 · Mar 31, 2026 | $51.3K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$10.84M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$17.22M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $10.16M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $2.56M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $10.59M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $11.47M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$4.78M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$6.39M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | −$6.38M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | −$111.5K |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $2.54M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $8.01M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $2.63M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $8.04M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $12.79M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $2.92M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $13.23M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $3.27M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.37 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$1.63 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$9.13 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$33.89 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.37 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$1.63 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$9.13 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$33.89 |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $3.52M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $10.36M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $3.76M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $12.93M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$1.43M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$4.02M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$4.81M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$15.08M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$1.58M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$4.25M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$4.81M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$15.19M |
| Revenue | Q3 2026 · Mar 31, 2026 | $3.92M |
| Revenue | Q3 2026 · Mar 31, 2026 | $12.88M |